Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health is a Finnish health technology company that aims to promote preventative health and help people stay healthy. Our blood analysis technology measures a large variety of biomarkers from a single blood sample and identifies personal risks for disease using unique health data assets. We provide people with comprehensive insights on health, help them make better decisions regarding their health and connect them with healthcare experts that offer preventative services for maintaining health. We strive to help millions of people prevent common lifestyle diseases in the future and, at the same time, to reduce the immense expenses of healthcare.
Contact us
ir@nightingalehealth.com
Share graph
Annual Report 2023–2024 has been published
Latest releases
Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer
Nightingale Health’s Board of Directors resolved on amendment to CEO’s incentive program
Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore
Nightingale Health to publish Financial Statements Release for financial year July 2023 – June 2024 on 20 September 2024
Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore
Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel
Subscribe to releases
Get the latest Nightingale Health releases delivered straight to your inbox.
Latest releases
Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer